FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to pharmacology, pathophysiology and physiology. The essence of the invention is the use of Gly-His-Lys-Val-Glu-Pro peptide, having the formula (NH2)Gly-His-Lys-Val-Glu-Pro (COOH), to improve learning ability and memory.
EFFECT: peptide helps improving learning ability and memory.
1 cl, 1 tbl
Title | Year | Author | Number |
---|---|---|---|
USE OF PEPTIDE Gly-His-Lus-Gly-Pro TO ACHIEVE ANXIOLYTIC EFFECT | 2019 |
|
RU2705592C1 |
HEXAPEPTIDE ELICITING MEMORY STIMULATING ACTIVITY | 1998 |
|
RU2131743C1 |
USE OF PEPTIDE Gly-His-Lys-Pro-Gly-Pro TO ACHIEVE ANALGESIC EFFECT IN PAIN CAUSED BY TEMPERATURE IRRITATION | 2018 |
|
RU2687740C1 |
ANXIOLYTIC AGENT AND PHARMACEUTICAL COMPOSITION WITH ANXIOLYTIC EFFECT | 1999 |
|
RU2155065C1 |
FAMILY OF PEPTIDES POSSESSING ANALGESIC ACTIVITY | 2005 |
|
RU2286169C1 |
USE OF THE PEPTIDE GLY-HIS-LYS-PRO-GLY-PRO TO ACHIEVE AN ANTIDEPRESSANT EFFECT | 2020 |
|
RU2747224C1 |
TREATMENT OF NEUROLOGICAL DISEASES | 2017 |
|
RU2755997C2 |
HEPTAPEPTIDE WITH ADAPTOGENIC AND ANXIOLYTIC ACTIVITY | 1999 |
|
RU2161500C1 |
RABIES VACCINE | 2014 |
|
RU2712743C2 |
VACCINATION USING THE ALPHA 3 DOMAIN OF MICA/B FOR CANCER TREATMENT | 2016 |
|
RU2747296C2 |
Authors
Dates
2021-02-16—Published
2020-07-06—Filed